Independent Research set a €122.00 ($141.86) price objective on Deutsche Boerse (ETR:DB1) in a research report report published on Monday morning. The brokerage currently has a neutral rating on the stock.

DB1 has been the subject of a number of other research reports. UBS Group set a €135.00 ($156.98) target price on Deutsche Boerse and gave the company a buy rating in a report on Monday, January 14th. Royal Bank of Canada set a €125.00 ($145.35) target price on Deutsche Boerse and gave the company a neutral rating in a report on Friday, December 7th. Nord/LB set a €108.56 ($126.23) target price on Deutsche Boerse and gave the company a neutral rating in a report on Tuesday, October 30th. DZ Bank reaffirmed a buy rating on shares of Deutsche Boerse in a report on Wednesday, October 31st. Finally, JPMorgan Chase & Co. set a €122.00 ($141.86) target price on Deutsche Boerse and gave the company a neutral rating in a report on Wednesday, February 13th. Eight investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The stock presently has a consensus rating of Hold and a consensus target price of €123.20 ($143.25).

DB1 stock opened at €111.05 ($129.13) on Monday. Deutsche Boerse has a twelve month low of €77.25 ($89.83) and a twelve month high of €111.20 ($129.30).

About Deutsche Boerse

Deutsche Börse Aktiengesellschaft operates as an exchange organization in Europe, America, and the Asia-Pacific. The company operates through four segments: Eurex, Xetra, Clearstream, and Market Data + Services. The Eurex segment engages in the electronic trading of European derivatives, commodities, and foreign exchange.

Featured Article: Market Capitalization in the Stock Market

Analyst Recommendations for Deutsche Boerse (ETR:DB1)

Receive News & Ratings for Deutsche Boerse Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Deutsche Boerse and related companies with MarketBeat.com's FREE daily email newsletter.